Aims: Traditional serrated adenoma (TSA) is the least common subtype of serrated colorectal polyp. Large protuberant lesions are easily recognised; however, the origins of TSAs are not known, and early forms have not been described. Some large TSAs present with a flat 'shoulder' component surrounding the central protuberant component. We hypothesised that small polyps with the same histology as these shoulder regions may represent early TSAs. Thus the primary aim of the study is to describe the histology of these presumptive early TSAs. Methods and results: We collected 70 small (<10 mm) polyps that may represent early TSAs on the basis of typical TSA cytology covering the luminal surface. We also identified 12 large TSAs with a shoulder component resembling these small polyps. The study polyp patients had a mean age of 58 years, and 54% were female; the polyps had a mean diameter of 4.1 mm and were predominantly distal (71%). Morphologically, slit-like serrations were present in 81%, ectopic crypt formations were present in 67%, and a villous component was present in 47%. These histological features were similar to those of the 12 shoulder lesions. Immunohistochemical stains showed an absence of b-catenin nuclear expression in 96% of the small polyps, retained expression of MLH1 in 100%, and Ki67 positivity restricted to the crypt bases and ectopic crypt formations. BRAF and KRAS mutations were identified in 47% and 31% of the polyps, respectively. BRAF-mutated polyps were more likely than KRASmutated polyps to arise in a precursor polyp (82% versus 18%, P < 0.001), and were more likely to have slit-like serrations (100% versus 73%, P = 0.003). Conclusions: These morphological, immunohistochemical and molecular findings are similar to what has been reported in large TSAs, and support the hypothesis that these polyps represent early forms of TSA.
Introduction
Serrated colorectal polyps fall into three major categories, namely hyperplastic polyps (HPs), sessile serrated polyps (SSPs), and traditional serrated adenomas (TSAs). 1 Of these, only SSPs and TSAs have significant malignant potential. Since the first report of TSA by Longacre and Fenoglio-Presier, 2 our understanding of the histology and molecular biology of this rare polyp has continued to improve. Clinically, TSAs tend to occur in older patients, more commonly in the distal colon and rectum, and have no significant gender predilection. [3] [4] [5] Histologically, the classic TSA is characterised by tubulovillous architecture, ectopic crypt formations, slit-like serrations, and typical cytology (cells with abundant intensely eosinophilic cytoplasm and centrally placed pencillate nuclei). Although not universally recognised, proximal TSAs that are often flat to the endoscopist have been described. 3, 4 At a molecular level, most TSAs show activation of the mitogen-activated protein kinase (MAPK) pathway, by either KRAS mutation in 22-42% or BRAF mutation in 48-67%. [4] [5] [6] [7] A small proportion are BRAF/KRAS wild-type, and these cases segregate best with the KRAS-mutated group. 3 WNT pathway activation resulting from PTPRK-RSPO3 fusions or RNF43 mutations occur in 71% of TSAs. 8 BRAF-mutated TSAs are more likely than KRAS-mutated TSAs to be proximal, to arise in a precursor polyp, and to show the CpG island methylator phenotype. 3, 9 Regardless of the BRAF or KRAS mutation status, effectively all TSAs are mismatch repair-proficient, even when they develop high-grade dysplasia or malignancy. 3 Despite these recent studies, there are still several controversial aspects of TSAs. Proximal and flat TSAs remain a matter of contention. The origin of TSAs is also not clear. Although many BRAF-mutated TSAs appear to have their origins in microvesicular hyperplastic polyps or SSPs, this is not universally accepted. 3, 4, 7, 10 The origins of KRAS-mutated TSAs remain even more obscure. In our practice, we often see large distal TSAs with a central protuberant portion but with a collar (or 'shoulder') of flat TSA at the periphery. Furthermore, we sometimes see small polyps with features very similar to those of these shoulder areas of larger TSAs. Because there is, at present, no good alternative, pathologists tend to diagnose these as tubular adenomas (albeit odd-looking) or SSPs with dysplasia (SSPD) when an adjacent SSP component is present. In the current literature, most described TSAs are >10 mm in size. However, TSAs cannot arise as large polyps. Despite this, there are currently no descriptions dedicated to small TSAs.
We hypothesised that early forms of TSA are recognisable and will have morphological, immunohistochemical and molecular features similar to those of the shoulder areas of large TSAs. Thus, the aims of the current study were to: (i) describe the histology of a series of small polyps that may represent early forms of TSA; (ii) perform a basic immunohistochemical (Ki67, b-catenin, and MLH1) and molecular (BRAF and KRAS mutation status) analysis of these polyps, and compare them with a control group of shoulder areas of larger TSAs; and (iii) identify clinicopathological differences between BRAF-mutated and KRAS-mutated early TSAs.
Materials and Methods

P A T I E N T S A N D S A M P L E S
The study group comprised cases collected in a prospective fashion by one of the authors (N.W.) during routine reporting at Envoi Specialist Pathologists in Brisbane, Australia, between January 2014 and June 2015. All cases were reviewed by two other pathologists (M.B. and C.R.). Demographic data including age, gender and polyp location were collected from the specimen request form or colonoscopy report. Distal location was assigned for polyps distal to the splenic flexure. The shoulder areas of larger TSAs, as a control group, were used for comparison with the study polyps, and were selected from cases reported in a previous study. 3 Ethics approval for the study was given by the QIMR Berghofer Medical Research Institute (P1298).
The study polyps were identified on the basis of size (≤10 mm) and histological features. The major histological feature was TSA-type cytology (eosinophilic cells with centrally placed pencillate nuclei) covering the luminal surface. Any components of villous growth, ectopic crypt formations and slit-like serrations were noted, but not required for inclusion. Villous growth was defined as 'a free-floating structure with epithelium surrounding a central core of lamina propria', an ectopic crypt formation was defined as 'epithelial buds with their bases not in contact with the muscularis mucosa', and a slit-like serration was defined as 'a narrow slit in the epithelium, similar to those seen in normal small bowel' (Figure 1 ). In cases in which there was a clear precursor polyp (e.g. microvesicular HP or SSP), the TSA-type cytology was only required to cover the luminal aspect of the discrete TSA-like area of these polyps.
I M M U N O H I S T O C H E M I S T R Y
Immunohistochemical staining for MLH1, b-catenin and Ki67 was performed on the study and control polyps as previously described. 3 
K R A S A N D B R A F M U T A T I O N T E S T I N G
Testing for KRAS and BRAF mutations was performed on the study and control polyps as previously described.
S T A T I S T I C A L A N A L Y S I S
Categorical variables were compared by the use of Fisher's exact test. Continuous variables were compared by the use of Student's t-test. A P < 0.05 was considered to be significant.
Results
C L I N I C O P A T H O L O G I C A L F E A T U R E S O F E A R L Y T S A S
Twelve control polyps with an adequate shoulder region for comparison were identified from the previously published cases 3 ( Figure 2 ). A further 70 polyps met the inclusion criteria for the study (Figure 3 ). The clinicopathological features of the study polyps are shown in Table 1 . The mean age of the patients was 58 years, and the mean polyp size was 4.1 mm. Thirty-eight (54%) of the patients were female.
The histological and immunohistochemical features are shown in Table 2 . For inclusion, all cases required TSA-type cytology covering the luminal aspect of the polyp. A precursor polyp was identified in 34 cases (49%), comprising 13 (19%) microvesicular HPs and 16 (22%) SSPs. Thirty-three (47%) had at least focal villous architecture, 57 (81%) had slit-like serrations, and 47 (67%) had ectopic crypt formations. By comparison, the shoulder areas of the control cohort showed focal villous change in three (25%), slit-like serrations in nine (75%), and ectopic crypt formations in seven (58%). There was no statistically significant difference between the study polyps and the control group (apart from origin in a precursor polyp).
The molecular features are shown in Table 3 . All of the study and control polyps retained nuclear staining for MLH1 (mismatch repair-proficient) (Figure 4D) . Nuclear staining for b-catenin was absent in 67 cases (96%) ( Figure 4B ) and very focal in three cases (4%). The three cases with focal positive staining were limited to occasional ectopic crypts; this staining pattern has been described previously.
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Ki67 showed the same pattern of staining in all study and control cases, with prominent staining in the crypts and in ectopic crypt formations, but an absence of staining at the luminal surface (Figure 4C ). There were no statistically significant differences in the immunohistochemical profiles of the study or control polyps.
Of the 70 study polyps, 33 (47%) were BRAFmutated, 22 (31%) were KRAS-mutated, and the remaining 15 cases were wild-type for both genes. All 12 of the control polyps were KRAS-mutated. The clinicopathological features of the KRAS-mutated versus BRAF-mutated polyps are shown in Table 3 . BRAF-mutated polyps were more likely to arise in a precursor polyp (82% versus 18%, P < 0.001) and were more likely to have slit-like serrations than KRAS-mutated polyps (100% versus 73%, P = 0.003) ( Table 3) .
Discussion
TSA has been described as the least common and least understood subtype of the serrated polyps. 12 Currently, it is unusual to diagnose TSA in a polyp <10 mm in size, but, logically, early and small forms of these polyps must exist. The aim of this study was to attempt to identify early forms of TSA. In all, 70 lesions measuring <10 mm (mean, 4.1 mm) were selected. We reasoned that, if these early putative TSAs shared morphological and immunohistochemical features with the shoulders of the larger TSAs, this would give support to the hypothesis that these are, in fact, small TSAs. Morphologically, there were no statistically significant differences between the shoulder areas of large TSAs and the small TSAs of the study group. Furthermore, the staining patterns for MLH1, Ki67 and b-catenin were the same in both groups. In particular, all cases were mismatch repairproficient, lacked Ki67 staining at the luminal surface, and nearly uniformly lacked nuclear staining for b-catenin. This immunohistochemical pattern is in stark contrast to those described for both SSPDs and conventional tubular adenomas, the two main differential diagnoses of early TSA. BRAF-mutated early TSAs arising in a precursor microvesicular HP or SSP can be confused with SSPD. This distinction may be clinically relevant. SSPD is an advanced polyp at a molecular level, with the potential for rapid transition to malignancy; in contrast, an early TSA is a relatively benign polyp with less immediate malignant potential. 13 The dysplastic portion of an SSPD should show overt cytological dysplasia with frequent mitoses, including at the luminal surface.
14 This is not a feature of TSA arising in a microvesicular HP or SSP. In addition, SSPD typically shows strong staining for Ki67 at the luminal surface in the areas of dysplasia, concordant with the atypical histology. 15 Nuclear b-catenin is also relatively common in the dysplastic areas, reflecting abnormalities in the WNT signalling pathway, and up to 75% lose staining for MLH1.
13-15 KRAS-mutated TSAs rarely arise in a precursor polyp, and can resemble conventional tubular adenomas. 10 However, tubular adenomas are overtly dysplastic, show increased Ki67 staining at the luminal surface, and frequently show nuclear b-catenin staining. 16, 17 Kim et al. previously reported 'tubular adenoma-like' lesions in 18% of TSAs as endoscopically flat-elevated lesions showing differences from conventional tubular adenomas in morphology and the distribution of Ki67. 4 Furthermore, MAPK pathway activation is rare in small tubular adenomas. 17 These findings of striking histological and immunohistochemical similarities between the study polyps and the shoulder areas of the larger TSAs, and the marked differences from the histology and immunohistochemical staining profiles of SSPD and tubular adenomas, support the hypothesis that these small polyps represent early forms of TSA. However, it must be acknowledged that, in diminutive cases with no precursor polyp, separation from a conventional tubular adenoma in routine reporting would be impractical and of limited clinical utility. Application of immunohistochemistry may resolve the uncertainty in most of these cases, but, given the limited clinical significance, is not justified. However, once slit-like serrations and ectopic crypt formations Table 1 . Clinicopathological features of the study and control polyps Table 2 . Histological and immunohistochemical features of the study polyps become identifiable, the diagnosis of a TSA should be considered, even if villous change is not apparent. Of the 70 polyps included in this study, 33 were BRAF-mutated, 22 were KRAS-mutated, and the remainder were BRAF/KRAS wild-type. These ratios are consistent with the published literature. [3] [4] [5] 9, 11 The major difference between the groups was the very frequent origin of the BRAF-mutated cases in a microvesicular HP or SSP. Previously, microvesicular HP or SSP has been associated with 15-57% of BRAF-mutated TSAs. [3] [4] [5] As might be expected, smaller lesions would be less likely to have overgrown their precursor, and it is therefore predictable that the association would be higher. Although it is likely that the remaining polyps overgrew a pre-existing lesion, a rare de-novo polyp cannot be excluded. In contrast, a precursor was uncommon among KRASmutated cases. However, four did show an adjacent goblet cell HP, suggesting that at least some may arise in these polyps. If KRAS-mutated hyperplastic, non-serrated aberrant crypt foci give rise to goblet cell hyperplastic polyps as suggested, 18 then perhaps they can also directly give rise to KRAS-mutated TSAs.
Recently, a Japanese group has published a series of polyps designated as 'superficially serrated adenoma'. 19 These polyps appear very similar morphologically to the KRAS-mutated early TSAs in our series. Interestingly, 19 of their 20 cases harboured a KRAS mutation, and 18 of the 20 cases showed either RSPO3 fusion or overexpression, a feature identified in up to one-third of larger TSAs. In the same study, the authors retrospectively identified large TSAs with 'superficially serrated adenoma' at the edges (very similar in appearance to the shoulder areas of our large TSAs), and found RSPO3 fusion or overexpression in 14 of 15 cases. Although the final interpretation by the authors was that these represent a separate precursor lesion to the TSA, in our opinion the morphology and molecular alterations are more suggestive of an early form of TSA. Nevertheless, there is a clear morphological and molecular relationship between these lesions and TSA, which are quite distinct from the alternative diagnoses of goblet cell HP, SSPD, or tubular adenoma.
In summary, we have reported a series of 70 small polyps that we feel represent the early forms of the large, well-recognised TSA. At present, many of these polyps would be diagnosed as 'odd-looking' tubular adenoma (KRAS-mutated forms) or possibly as SSPDs (BRAF-mutated forms). Careful attention to the morphology, in particular TSA-type cytological changes with concurrent slit-like serrations and ectopic crypt formations, can provide clues to the diagnosis. Prospective studies are needed to understand the clinical significance of these lesions. It is currently unknown whether a 3-year colonoscopy surveillance interval, as currently recommended for usual TSA, is justified for early forms of TSA.
